1. Home
  2. KURA vs FSBC Comparison

KURA vs FSBC Comparison

Compare KURA & FSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • FSBC
  • Stock Information
  • Founded
  • KURA 2014
  • FSBC 2002
  • Country
  • KURA United States
  • FSBC United States
  • Employees
  • KURA N/A
  • FSBC N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • FSBC Banks
  • Sector
  • KURA Health Care
  • FSBC Finance
  • Exchange
  • KURA Nasdaq
  • FSBC Nasdaq
  • Market Cap
  • KURA 611.7M
  • FSBC 653.4M
  • IPO Year
  • KURA N/A
  • FSBC 2021
  • Fundamental
  • Price
  • KURA $8.25
  • FSBC $31.37
  • Analyst Decision
  • KURA Strong Buy
  • FSBC Buy
  • Analyst Count
  • KURA 10
  • FSBC 4
  • Target Price
  • KURA $27.13
  • FSBC $36.13
  • AVG Volume (30 Days)
  • KURA 1.8M
  • FSBC 46.3K
  • Earning Date
  • KURA 02-26-2025
  • FSBC 01-27-2025
  • Dividend Yield
  • KURA N/A
  • FSBC 2.55%
  • EPS Growth
  • KURA N/A
  • FSBC N/A
  • EPS
  • KURA N/A
  • FSBC 2.26
  • Revenue
  • KURA N/A
  • FSBC $119,214,000.00
  • Revenue This Year
  • KURA N/A
  • FSBC N/A
  • Revenue Next Year
  • KURA $280.91
  • FSBC $13.57
  • P/E Ratio
  • KURA N/A
  • FSBC $13.89
  • Revenue Growth
  • KURA N/A
  • FSBC 4.22
  • 52 Week Low
  • KURA $6.98
  • FSBC $21.10
  • 52 Week High
  • KURA $24.17
  • FSBC $35.13
  • Technical
  • Relative Strength Index (RSI)
  • KURA 47.12
  • FSBC 60.31
  • Support Level
  • KURA $7.87
  • FSBC $30.11
  • Resistance Level
  • KURA $8.55
  • FSBC $31.94
  • Average True Range (ATR)
  • KURA 0.55
  • FSBC 0.89
  • MACD
  • KURA 0.03
  • FSBC 0.16
  • Stochastic Oscillator
  • KURA 43.48
  • FSBC 84.42

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About FSBC Five Star Bancorp

Five Star Bancorp is a California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts.

Share on Social Networks: